Your browser doesn't support javascript.
loading
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.
Selvarajah, Shamini; Schrader, Kasmintan A; Kolinsky, Michael P; Rendon, Ricardo A; El Hallani, Soufiane; Fleshner, Neil E; Hotte, Sebastien J; Lorentz, Justin; Panabaker, Karen; Perrier, Renée; Pouliot, Frédéric; Spatz, Alan; Yip, Stephen; Chi, Kim N.
Afiliação
  • Selvarajah S; Department of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network (UHN), Toronto, ON, Canada.
  • Schrader KA; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Kolinsky MP; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Rendon RA; Hereditary Cancer Program, BC Cancer, Vancouver, BC, Canada.
  • El Hallani S; Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, AB, Canada.
  • Fleshner NE; Department of Urology, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
  • Hotte SJ; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
  • Lorentz J; Division of Urology, Departments of Surgery and Surgical Oncology, University Health Network, Toronto, ON, Canada.
  • Panabaker K; Department of Oncology, McMaster University, Hamilton, ON, Canada.
  • Perrier R; Genetics and High Risk Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Pouliot F; Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, ON, Canada.
  • Spatz A; Department of Medical Genetics, Alberta Children's Hospital and Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Yip S; Divison of Urology, Department of Surgery, CHU de Québec and Laval University, Quebec, QC, Canada.
  • Chi KN; Department of Laboratory Medicine, McGill University Health Centre, Department of Pathology, McGill University, Research Molecular Pathology Center, Lady Davis Institute, Montreal, QC, Canada.
Can Urol Assoc J ; 16(10): 321-332, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36240332

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Revista: Can Urol Assoc J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Revista: Can Urol Assoc J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Canadá